The clinical efficacy of angiotensin II type1 receptor blockers on inflammatory markers in patients with hypertension: a multicenter randomized-controlled trial; MUSCAT-3 study.

Umebayashi, Ryoko; Uchida, Haruhito A; Okuyama, Yuka; Kakio, Yuki; Hanayama, Yoshihisa; Shikata, Kenichi; Wada, Jun

Umebayashi, Ryoko; Uchida, Haruhito A; Okuyama, Yuka; Kakio, Yuki; Hanayama, Yoshihisa; Shikata, Kenichi; Wada, Jun.

Afiliação

Umebayashi R; a Department of Nephrology, Rheumatology, Endocrinology and Metabolism , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.
Uchida HA; a Department of Nephrology, Rheumatology, Endocrinology and Metabolism , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.
Okuyama Y; b Department of Chronic Kidney Disease and Cardiovascular Disease , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.
Kakio Y; a Department of Nephrology, Rheumatology, Endocrinology and Metabolism , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.
Hanayama Y; a Department of Nephrology, Rheumatology, Endocrinology and Metabolism , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.
Shikata K; a Department of Nephrology, Rheumatology, Endocrinology and Metabolism , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.
Wada J; c Department of General Medicine , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan.

Biomarkers ; 24(3): 255-261, 2019 May.

Article em En | MEDLINE | ID: mdl-30444137

Assuntos

Bloqueadores do Receptor Tipo 1 de Angiotensina II/administração & dosagem; Hipertensão/tratamento farmacológico; Inflamação/tratamento farmacológico; Irbesartana/administração & dosagem; Idoso; Angiotensina II/sangue; Biomarcadores/sangue; Pressão Sanguínea/efeitos dos fármacos; Feminino; Humanos; Hipertensão/sangue; Hipertensão/patologia; Inflamação/sangue; Inflamação/patologia; Masculino; Pessoa de Meia-Idade; Estresse Oxidativo/efeitos dos fármacos

Palavras-chave

Angiotensin II receptor blocker; albuminuria; hypertension; inflammation; oxidative stress

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bloqueadores do Receptor Tipo 1 de Angiotensina II / Irbesartana / Hipertensão / Inflamação Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biomarkers Assunto da revista: BIOQUIMICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google